Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corporation Common Stock (NY: CNC )

62.25 -0.62 (-0.99%)
Official Closing Price Updated: 6:30 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Many stocks flashed buy signals as the major indexes rose to or above key levels. 
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's... 
Via Benzinga
3 Stocks With Strong Capital Returns and Insider Buying Signals
Insider buying spiked for these stocks in Q4, pointing to higher prices in 2025. Robust capital returns are central to the outlook. 
Via MarketBeat
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Via Benzinga
(CNC) - Analyzing Centene's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Via Benzinga
Insiders Are Buying These 3 Large Cap Stocks
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. 
Via Talk Markets
Topics Stocks / Equities
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 14
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 9-13, 2024. 
Via Talk Markets
Topics Stocks / Equities
This PayPal Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
$1000 Invested In Centene 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Centene Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Via Benzinga
Looking Into Centene's Recent Short Interest
Via Benzinga
C-Suite Buy of the Week: Executives' Investments Offer Clues to Market Directions
Via Benzinga
Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
Centene reveals 2025 guidance, expecting revenues up to $169.5 bilion and adjusted EPS over $7.25. HBR and SG&A ratios align with strategic targets. 
Via Benzinga
UnitedHealth Stock Rises; Analyst Backs UnitedHealthcare Parent After CEO's Murder
UnitedHealth stock recovered some lost ground as Wall Street assesses whether the killing of the UnitedHealthcare insurance division CEO will hurt profitability. 
Via Investor's Business Daily
Stock Market Hits Highs On Salesforce, Tech Earnings; Bitcoin Tops $100,000, Briefly: Weekly Review
Salesforce and mostly positive tech earnings buoyed the major indexes. 
Via Investor's Business Daily
(CNC) - Analyzing Centene's Short Interest
Via Benzinga
Centene Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Key Takeaways From Centene Analyst Ratings
Via Benzinga
UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies
A federal judge ordered a rerating of the its Medicare Advantage star ratings. Humana also rallied. 
Via Investor's Business Daily
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. Let’s take a closer look at the transactions for those interested in trading like the insiders. 
Via Talk Markets
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios. 
Via MarketBeat
Earnings Outlook For Centene
Via Benzinga
S&P 500, Nasdaq Rise Sharply Ending 3-Day Losing Streak; Viking Therapeutics Surge, While Capri’s Shares Slump
US benchmark equity averages rose on Friday as the market ended a three-day losing streak. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Centene (CNC) Q3 2024 Earnings Call Transcript
CNC earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook
Centene reported Q3 sales of $42.02 billion, surpassing expectations. Adjusted EPS reached $1.62, driven by Medicaid rate increases and membership growth. 
Via Benzinga
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.